X-linked retinitis pigmentosa
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In these kindreds the XLRP locus shows close linkage with Xp21 marker loci OTC and DXS206.
|
2568332 |
1989 |
X-linked muscular dystrophy with abnormal dystrophin
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The majority of mutations in Xp21-linked muscular dystrophy (MD) can be identified by PCR or Southern blotting, as deletions or duplications of groups of exons in the dystrophin gene, but it is not always possible to predict how much altered dystrophin, if any, will be produced.
|
7684887 |
1993 |
X-linked Adrenal Hypoplasia
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Array CGH study confirmed the existence of a deletion in Xp21 of the genes responsible for DMD, GKD and the congenital adrenal hypoplasia (gene DAX1 or NROB1 gene: Xp21.3-21.2).
|
22308874 |
2011 |
X-linked Adrenal Hypoplasia
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
One of the boys with DMD, GK, and AHC is shown by pulsed-field-gel electrophoresis to have a deletion which has a proximal endpoint at least 500 kb distal from the pERT87 (DXS164) locus.
|
2837087 |
1988 |
X-linked Adrenal Hypoplasia
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Molecular mapping revealed that the deletion extended from the 3' end of the DMD gene to a site telomeric to the loci for X-linked congenital adrenal hypoplasia and glycerol kinase deficiency.
|
7955386 |
1994 |
X-linked Adrenal Hypoplasia
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
This is a case report of a boy with X-linked AHC associated with Duchenne muscular dystrophy, whose clinical presentation led to analysis of the DAX-1, glycerol kinase (GK1) and dystrophin genes, which were amplified by polymerase chain reaction, with Southern blot analysis of the AHC locus.
|
19339795 |
2009 |
X-linked Adrenal Hypoplasia
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
For example, the map suggests that the adrenal hypoplasia congenita and glycerol kinase genes are physically close to each other, are within 1-2 Mb of the telomeric end of the Duchenne muscular dystrophy (DMD) gene, and are nearer to the DMD locus than to the more distal marker DXS28 (C7).
|
1463011 |
1992 |
X- linked recessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Widened subarachnoid space
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Weight less than 3rd percentile
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne muscular dystrophy is a muscle wasting disease that results from a dystrophin deficiency in skeletal and cardiac muscle.
|
11984871 |
2002 |
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne muscular dystrophy (DMD) is a lethal muscle wasting disease caused by a lack of dystrophin, which eventually leads to apoptosis of muscle cells and impaired muscle contractility.
|
29317080 |
2018 |
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease caused by the lack of dystrophin in muscle fibers that is currently without curative treatment.
|
31683098 |
2019 |
Wasting Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Duchenne muscular dystrophy is a lethal X-linked muscle wasting disease due to mutations of the dystrophin gene leading to distinct susceptibility to degeneration and fibrosis among skeletal muscles.
|
30953145 |
2019 |
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disease that is characterized by muscle dystrophin deficiency.
|
16627883 |
2006 |
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne/Becker muscular dystrophy (DMD/BMD) is a progressive muscle-wasting disease.
|
1362673 |
1992 |
Wasting Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Out of three mutations in the dystrophin gene that cause Duchenne muscular dystrophy (DMD), the most common, serious childhood muscle wasting disease, two are genomic deletions of one or more exons that disrupt the reading frame.
|
18570328 |
2009 |
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne muscular dystrophy is a fatal muscle wasting disease that is characterized by a deficiency in the protein dystrophin.
|
19359520 |
2009 |
Wasting Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Indeed, the loss of dystrophin protein expression causes the muscle wasting disease, Duchenne muscular dystrophy (DMD).
|
30349485 |
2018 |
Wasting Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Duchenne and Becker muscular dystrophies (DMD and BMD) are muscle-wasting diseases caused by mutations in the DMD gene-encoding dystrophin.
|
22589245 |
2012 |
Waddling gait
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Vitelliform Macular Dystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
|
17041906 |
2007 |
Vitelliform Macular Dystrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
As of February 2012, 583 DMD and 105 BMD patients were registered.
|
23601510 |
2013 |
Vitelliform Macular Dystrophy
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, small quantities of normal mRNA are also transcribed and these are sufficient to produce a reduced amount of normal molecular weight dystrophin and give rise to a milder BMD phenotype.
|
8730289 |
1996 |
Vitelliform Macular Dystrophy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genotype-phenotype correlation and germline mosaicism in DMD/BMD patients with deletions of the dystrophin gene.
|
1864612 |
1991 |